Maravai LifeSciences Holdings, Inc.
corporate_fare Company Profile
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for MRVI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-07, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for MRVI spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Maravai Q2 revenue climbs 8.5% and gross margin doubles on restructuring, but cash dwindles to $70M after debt paydown
- Maravai LifeSciences Refinances Debt, Reduces Principal by $92.9M, Extends Maturity to 2032
- Maravai LifeSciences Reports Strong Q1 2026 Results, Prepaying $50M Debt, but Warns of Future Revenue Headwinds
- Maravai LifeSciences Raises 2026 Guidance as Q1 Revenue Jumps 41%, EBITDA Hits $20.3M
- Maravai LifeSciences Reports Strong Q1 Results, Significantly Raises Full-Year Guidance
Financial Snapshot
Short Interest & Short Volume
4.65 days to coverFINRA reported short interest of 12,372,302 shares in MRVI as of the September 15, 2026 settlement, a 12.9% increase from the prior period — about 4.7 days to cover at its recent average daily volume. On October 2, 2026, 51.5% of MRVI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.